EUVIMEDOpdag EUVIMED
Crossref

Molecular Mechanism of Baicalin in Ameliorating Chronic Pancreatitis: Insights From Network Pharmacology and Metabolomics

Ruyang Cheng iD, Weining Song, Yu Wang, Yehao Wang, Xiaomin Xu, Fang Lu, Donghua Yu iD, Pingping Chen, Shumin Liu iD

Biomedical Chromatography · 2026-08 · 40 (8)

DOI: 10.1002/bmc.70534 ↗

At a glance

Journal article in Biomedical Chromatography, published online on 2026-07-03. Written by Ruyang Cheng and 8 co-authors. Institution: Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China. Major MEDLINE topics: Pancreatitis, Chronic, Flavonoids, Metabolome. 69 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In this study, we explored the therapeutic effects and mechanisms of baicalin (BA) in a dibutyltin dichloride (DBTC)–induced chronic pancreatitis (CP) rat model using metabolomics and network pharmacology. The results showed that BA significantly reduced inflammatory cell infiltration and fibrosis in pancreatic tissues, lowered serum levels of interleukin (IL)‐1β, IL‐6, tumor necrosis factor‐alpha (TNF‐α), amylase (AMS), and lipopolysaccharide (LPS) and thereby decreased expression of alpha‐smooth muscle actin (α‐SMA) and fibronectin (FN) in pancreatic tissues. Metabolomic analyses revealed that BA influences multiple metabolic pathways, including glycerophospholipid and arachidonic acid metabolism, in serum and urine. Network pharmacology identified key targets, such as phospholipase A2 group IVA (PLA2G4A) and transient receptor potential vanilloid 4 (TRPV4), which are primarily involved in IL‐17 signaling, as well as other pathways beyond inflammation. Further integrated analysis demonstrated that BA inhibits pancreatic stellate cell activation and reduces pancreatic fibrosis by regulating metabolites, such as arachidonic acid, that act on the PLA2G4A/TRPV4 and transforming growth factor‐beta 1 (TGF‐β1)/SMAD family member 3 (SMAD3) pathways. Molecular docking studies confirmed that BA binds strongly to these targets. In summary, BA exerts anti‐inflammatory and antifibrotic effects through multiple targets and pathways, thereby alleviating the pathological progression of CP.

Subjects

MeSH terms (MEDLINE)

Pancreatitis, ChronicFlavonoidsMetabolomeAnimalsMetabolomicsRatsMaleNetwork PharmacologyMolecular Docking SimulationRats, Sprague-DawleyOrganotin CompoundsPancreas

Author keywords

baicalinchronic pancreatitisinflammationmetabolomicsnetwork pharmacology

Substances

baicalinFlavonoidsOrganotin Compoundsdibutyldichlorotin

Authors and institutions

  • Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.

ORCID profiles: Ruyang Cheng, Donghua Yu, Shumin Liu

Cite

APA

Cheng, R., Song, W., Wang, Y., Wang, Y., Xu, X., Lu, F., Yu, D., Chen, P., & Liu, S. (2026). Molecular Mechanism of Baicalin in Ameliorating Chronic Pancreatitis: Insights From Network Pharmacology and Metabolomics. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70534

Vancouver

Cheng R, Song W, Wang Y, Wang Y, Xu X, Lu F, et al. Molecular Mechanism of Baicalin in Ameliorating Chronic Pancreatitis: Insights From Network Pharmacology and Metabolomics. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70534

BibTeX
@article{Cheng2026,
  author = {Cheng, Ruyang and Song, Weining and Wang, Yu and Wang, Yehao and Xu, Xiaomin and Lu, Fang and Yu, Donghua and Chen, Pingping and Liu, Shumin},
  title = {Molecular Mechanism of Baicalin in Ameliorating Chronic Pancreatitis: Insights From Network Pharmacology and Metabolomics},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1002/bmc.70534}
}
Start for free →